symmetric dimethylarginine has been researched along with Shock, Septic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, AC; Lambden, S; Leiper, J; Piper, S; Tomlinson, J | 1 |
| Bestle, MH; Haase, N; Itenov, TS; Johansson, PI; Mortensen, KM; Müller, RB; Olsen, NV; Ostrowski, SR; Perner, A; Søe-Jensen, P | 1 |
2 other study(ies) available for symmetric dimethylarginine and Shock, Septic
| Article | Year |
|---|---|
Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity.
Topics: Amidohydrolases; Arginine; Biomarkers; Humans; Organ Dysfunction Scores; Polymorphism, Single Nucleotide; Protective Agents; Shock, Septic; Statistics, Nonparametric; Time Factors | 2018 |
High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis.
Topics: Aged; Arginine; Female; Humans; Male; Middle Aged; Nitric Oxide; Proportional Hazards Models; Sepsis; Shock, Septic | 2016 |